TCM

TCG Crossover Management Portfolio holdings

AUM $3.02B
1-Year Est. Return 698.5%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+698.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.02B
AUM Growth
+$989M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
48
New
Increased
Reduced
Closed

Top Buys

1
+$62.3M
2
+$57.4M
3
+$42.1M
4
ADCT icon
ADC Therapeutics
ADCT
+$40.6M
5
IMVT icon
Immunovant
IMVT
+$37M

Top Sells

1
+$62.7M
2
+$34.2M
3
+$30.7M
4
COGT icon
Cogent Biosciences
COGT
+$26.1M
5
ATXS
Astria Therapeutics
ATXS
+$20.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
26
Agios Pharmaceuticals
AGIO
$1.69B
$32.2M 1.06%
1,181,841
-248,200
ARVN icon
27
Arvinas
ARVN
$861M
$31.6M 1.05%
2,666,216
+1,048,851
RLAY icon
28
Relay Therapeutics
RLAY
$1.75B
$27.2M 0.9%
3,220,186
+1,409,835
JANX icon
29
Janux Therapeutics
JANX
$816M
$24.7M 0.82%
+1,789,617
TRDA icon
30
Entrada Therapeutics
TRDA
$451M
$21.5M 0.71%
2,088,392
+1,503,437
MBX
31
MBX Biosciences
MBX
$1.46B
$20.5M 0.68%
650,000
UPB
32
Upstream Bio Inc
UPB
$409M
$20.2M 0.67%
743,886
-1,373,217
SLN
33
Silence Therapeutics
SLN
$294M
$18.4M 0.61%
3,033,560
URGN icon
34
UroGen Pharma
URGN
$929M
$16.8M 0.56%
717,347
ALEC icon
35
Alector
ALEC
$225M
$15.6M 0.52%
+10,000,000
MNPR icon
36
Monopar Therapeutics
MNPR
$357M
$9.27M 0.31%
141,915
-11,085
AVTX icon
37
Avalo Therapeutics
AVTX
$329M
$8.77M 0.29%
483,000
MAZE
38
Maze Therapeutics
MAZE
$2.2B
$7.2M 0.24%
+173,816
MIRM icon
39
Mirum Pharmaceuticals
MIRM
$5.43B
$4.9M 0.16%
+62,049
LONA
40
LeonaBio Inc
LONA
$53.8M
$3.35M 0.11%
+464,398
KRRO icon
41
Korro Bio
KRRO
$110M
$3.33M 0.11%
416,301
VTYX icon
42
Ventyx Biosciences
VTYX
$1B
$2.86M 0.09%
316,195
VTGN icon
43
VistaGen Therapeutics
VTGN
$23.6M
$1.77M 0.06%
2,676,580
ADVM
44
DELISTED
Adverum Biotechnologies
ADVM
– –
-1,668,174
ATXS
45
DELISTED
Astria Therapeutics
ATXS
– –
-2,761,861
IRON icon
46
Disc Medicine
IRON
$2.52B
– –
-465,257
PEPG icon
47
PepGen
PEPG
$448M
– –
-1,200,000
TRML
48
DELISTED
Tourmaline Bio
TRML
– –
-1,311,783
1
2